Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 134 entries
Sorted by: Best Match Show Resources per page
The Development of .

Frontiers in immunology

Boyle MJ, Jagannathan P, Bowen K, McIntyre TI, Vance HM, Farrington LA, Schwartz A, Nankya F, Naluwu K, Wamala S, Sikyomu E, Rek J, Greenhouse B, Arinaitwe E, Dorsey G, Kamya MR, Feeney ME.
PMID: 29097996
Front Immunol. 2017 Oct 19;8:1329. doi: 10.3389/fimmu.2017.01329. eCollection 2017.

Cytokine-producing CD4 T cells have important roles in immunity against

Cite
Boyle MJ, Jagannathan P, Bowen K, et al. The Development of . Front Immunol. 2017;8:1329doi: 10.3389/fimmu.2017.01329.
Boyle, M. J., Jagannathan, P., Bowen, K., McIntyre, T. I., Vance, H. M., Farrington, L. A., Schwartz, A., Nankya, F., Naluwu, K., Wamala, S., Sikyomu, E., Rek, J., Greenhouse, B., Arinaitwe, E., Dorsey, G., Kamya, M. R., & Feeney, M. E. (2017). The Development of . Frontiers in immunology, 81329. https://doi.org/10.3389/fimmu.2017.01329
Boyle, Michelle J, et al. "The Development of ." Frontiers in immunology vol. 8 (2017): 1329. doi: https://doi.org/10.3389/fimmu.2017.01329
Boyle MJ, Jagannathan P, Bowen K, McIntyre TI, Vance HM, Farrington LA, Schwartz A, Nankya F, Naluwu K, Wamala S, Sikyomu E, Rek J, Greenhouse B, Arinaitwe E, Dorsey G, Kamya MR, Feeney ME. The Development of . Front Immunol. 2017 Oct 19;8:1329. doi: 10.3389/fimmu.2017.01329. eCollection 2017. PMID: 29097996; PMCID: PMC5653696.
Copy Download .nbib Format: NLM
Nonpharmacological treatment of rhinoconjunctivitis and rhinosinusitis.

Journal of allergy

Mösges R, Baena-Cagnani CE, Passali D.
PMID: 25587288
J Allergy (Cairo). 2014;2014:416236. doi: 10.1155/2014/416236. Epub 2014 Dec 21.

No abstract available.

Cite
Mösges R, Baena-Cagnani CE, Passali D. Nonpharmacological treatment of rhinoconjunctivitis and rhinosinusitis. J Allergy (Cairo). 2014;2014:416236doi: 10.1155/2014/416236.
Mösges, R., Baena-Cagnani, C. E., & Passali, D. (2014). Nonpharmacological treatment of rhinoconjunctivitis and rhinosinusitis. Journal of allergy, 2014416236. https://doi.org/10.1155/2014/416236
Mösges, Ralph, et al. "Nonpharmacological treatment of rhinoconjunctivitis and rhinosinusitis." Journal of allergy vol. 2014 (2014): 416236. doi: https://doi.org/10.1155/2014/416236
Mösges R, Baena-Cagnani CE, Passali D. Nonpharmacological treatment of rhinoconjunctivitis and rhinosinusitis. J Allergy (Cairo). 2014;2014:416236. doi: 10.1155/2014/416236. Epub 2014 Dec 21. PMID: 25587288; PMCID: PMC4283391.
Copy Download .nbib Format: NLM
[The family environment of the schizophrenic; observations on a clinical case].

L' Evolution psychiatrique

SIVADON P, MISES R, MISES J.
PMID: 13161887
Evol Psychiatr (Paris). 1954 Jan-Mar;1:147-57.

No abstract available.

Cite
SIVADON P, MISES R, MISES J. Le milieu familial du schizophrène; réflexions sur un cas clinique. [The family environment of the schizophrenic; observations on a clinical case]. Evol Psychiatr (Paris). 1954;1:147-57
SIVADON, P., MISES, R., & MISES, J. (1954). Le milieu familial du schizophrène; réflexions sur un cas clinique. [The family environment of the schizophrenic; observations on a clinical case]. L' Evolution psychiatrique, 1147-57.
SIVADON, P, et al. "Le milieu familial du schizophrène; réflexions sur un cas clinique." [The family environment of the schizophrenic; observations on a clinical case]. L' Evolution psychiatrique vol. 1 (1954): 147-57.
SIVADON P, MISES R, MISES J. Le milieu familial du schizophrène; réflexions sur un cas clinique. [The family environment of the schizophrenic; observations on a clinical case]. Evol Psychiatr (Paris). 1954 Jan-Mar;1:147-57. Undetermined. PMID: 13161887.
Copy Download .nbib Format: NLM
Efficacy and tolerability of levocabastine and azelastine nasal sprays for the treatment of allergic rhinitis.

Mediators of inflammation

Mösges R, Spaeth J, Klimek L.
PMID: 18475683
Mediators Inflamm. 1995;4(7):S11-5. doi: 10.1155/S0962935195000780.

Levocabastine and azelastine are currently the only antihistamines available as nasal sprays for the topical therapy of seasonal allergic rhinitis. The present study was undertaken to compare the onset of action, efficacy and tolerability of these two agents in...

Cite
Mösges R, Spaeth J, Klimek L. Efficacy and tolerability of levocabastine and azelastine nasal sprays for the treatment of allergic rhinitis. Mediators Inflamm. 1995;4(7):S11-5doi: 10.1155/S0962935195000780.
Mösges, R., Spaeth, J., & Klimek, L. (1995). Efficacy and tolerability of levocabastine and azelastine nasal sprays for the treatment of allergic rhinitis. Mediators of inflammation, 4(7), S11-5. https://doi.org/10.1155/S0962935195000780
Mösges, R, et al. "Efficacy and tolerability of levocabastine and azelastine nasal sprays for the treatment of allergic rhinitis." Mediators of inflammation vol. 4,7 (1995): S11-5. doi: https://doi.org/10.1155/S0962935195000780
Mösges R, Spaeth J, Klimek L. Efficacy and tolerability of levocabastine and azelastine nasal sprays for the treatment of allergic rhinitis. Mediators Inflamm. 1995;4(7):S11-5. doi: 10.1155/S0962935195000780. PMID: 18475683; PMCID: PMC2365678.
Copy Download .nbib Format: NLM
They settle doctor-patient disputes.

Medical economics

MENGES R.
PMID: 14826165
Med Econ. 1951 Apr;28(4):60-3; passim.

No abstract available.

Cite
MENGES R. They settle doctor-patient disputes. Med Econ. 1951;28(4):60-3; passim
MENGES, R. (1951). They settle doctor-patient disputes. Medical economics, 28(4), 60-3; passim.
MENGES, R. "They settle doctor-patient disputes." Medical economics vol. 28,4 (1951): 60-3; passim.
MENGES R. They settle doctor-patient disputes. Med Econ. 1951 Apr;28(4):60-3; passim. PMID: 14826165.
Copy Download .nbib Format: NLM
The Distribution of Certain Oxidative Enzymes in the Ciliary Body.

Transactions of the American Ophthalmological Society

Friedenwald JS, Herrmann H, Moses R.
PMID: 16693309
Trans Am Ophthalmol Soc. 1943;41:141-56.

No abstract available.

Cite
Friedenwald JS, Herrmann H, Moses R. The Distribution of Certain Oxidative Enzymes in the Ciliary Body. Trans Am Ophthalmol Soc. 1943;41:141-56
Friedenwald, J. S., Herrmann, H., & Moses, R. (1943). The Distribution of Certain Oxidative Enzymes in the Ciliary Body. Transactions of the American Ophthalmological Society, 41141-56.
Friedenwald, J S, et al. "The Distribution of Certain Oxidative Enzymes in the Ciliary Body." Transactions of the American Ophthalmological Society vol. 41 (1943): 141-56.
Friedenwald JS, Herrmann H, Moses R. The Distribution of Certain Oxidative Enzymes in the Ciliary Body. Trans Am Ophthalmol Soc. 1943;41:141-56. PMID: 16693309; PMCID: PMC1315082.
Copy Download .nbib Format: NLM
Sub-optimal CD4 reconstitution despite viral suppression in an urban cohort on antiretroviral therapy (ART) in sub-Saharan Africa: frequency and clinical significance.

AIDS research and therapy

Nakanjako D, Kiragga A, Ibrahim F, Castelnuovo B, Kamya MR, Easterbrook PJ.
PMID: 18957083
AIDS Res Ther. 2008 Oct 28;5:23. doi: 10.1186/1742-6405-5-23.

BACKGROUND: A proportion of individuals who start antiretroviral therapy (ART) fail to achieve adequate CD4 cell reconstitution despite sustained viral suppression. We determined the frequency and clinical significance of suboptimal CD4 reconstitution despite viral suppression (SO-CD4) in an urban...

Cite
Nakanjako D, Kiragga A, Ibrahim F, et al. Sub-optimal CD4 reconstitution despite viral suppression in an urban cohort on antiretroviral therapy (ART) in sub-Saharan Africa: frequency and clinical significance. AIDS Res Ther. 2008;5:23doi: 10.1186/1742-6405-5-23.
Nakanjako, D., Kiragga, A., Ibrahim, F., Castelnuovo, B., Kamya, M. R., & Easterbrook, P. J. (2008). Sub-optimal CD4 reconstitution despite viral suppression in an urban cohort on antiretroviral therapy (ART) in sub-Saharan Africa: frequency and clinical significance. AIDS research and therapy, 523. https://doi.org/10.1186/1742-6405-5-23
Nakanjako, Damalie, et al. "Sub-optimal CD4 reconstitution despite viral suppression in an urban cohort on antiretroviral therapy (ART) in sub-Saharan Africa: frequency and clinical significance." AIDS research and therapy vol. 5 (2008): 23. doi: https://doi.org/10.1186/1742-6405-5-23
Nakanjako D, Kiragga A, Ibrahim F, Castelnuovo B, Kamya MR, Easterbrook PJ. Sub-optimal CD4 reconstitution despite viral suppression in an urban cohort on antiretroviral therapy (ART) in sub-Saharan Africa: frequency and clinical significance. AIDS Res Ther. 2008 Oct 28;5:23. doi: 10.1186/1742-6405-5-23. PMID: 18957083; PMCID: PMC2605744.
Copy Download .nbib Format: NLM
On the sustainability of guideline implementation.

The World Allergy Organization journal

Köberlein J, Vent J, Mösges R.
PMID: 23282944
World Allergy Organ J. 2010 Nov;3(11):258-61. doi: 10.1097/WOX.0b013e3181fdfc7a.

BACKGROUND: : Allergic rhinitis (AR) is a disorder associated with a high financial burden and is considered an important risk factor for the development of asthma. The ARIA guideline (Allergic Rhinitis and its Impact on Asthma) addresses this problem...

Cite
Köberlein J, Vent J, Mösges R. On the sustainability of guideline implementation. World Allergy Organ J. 2010;3(11):258-61doi: 10.1097/WOX.0b013e3181fdfc7a.
Köberlein, J., Vent, J., & Mösges, R. (2010). On the sustainability of guideline implementation. The World Allergy Organization journal, 3(11), 258-61. https://doi.org/10.1097/WOX.0b013e3181fdfc7a
Köberlein, Juliane, et al. "On the sustainability of guideline implementation." The World Allergy Organization journal vol. 3,11 (2010): 258-61. doi: https://doi.org/10.1097/WOX.0b013e3181fdfc7a
Köberlein J, Vent J, Mösges R. On the sustainability of guideline implementation. World Allergy Organ J. 2010 Nov;3(11):258-61. doi: 10.1097/WOX.0b013e3181fdfc7a. PMID: 23282944; PMCID: PMC3651109.
Copy Download .nbib Format: NLM
Manifesto on small airway involvement and management in asthma and chronic obstructive pulmonary disease: an Interasma (Global Asthma Association - GAA) and World Allergy Organization (WAO) document endorsed by Allergic Rhinitis and its Impact on Asthma (ARIA) and Global Allergy and Asthma European Network (GA.

Asthma research and practice

Braido F, Scichilone N, Lavorini F, Usmani OS, Dubuske L, Boulet LP, Mosges R, Nunes C, Sánchez-Borges M, Ansotegui IJ, Ebisawa M, Levi-Schaffer F, Rosenwasser LJ, Bousquet J, Zuberbier T, Canonica GW.
PMID: 27965780
Asthma Res Pract. 2016 Oct 28;2:12. doi: 10.1186/s40733-016-0027-5. eCollection 2016.

Evidence that enables us to identify, assess, and access the small airways in asthma and chronic obstructive pulmonary disease (COPD) has led INTERASMA (Global Asthma Association) and WAO to take a position on the role of the small airways...

Cite
Braido F, Scichilone N, Lavorini F, et al. Manifesto on small airway involvement and management in asthma and chronic obstructive pulmonary disease: an Interasma (Global Asthma Association - GAA) and World Allergy Organization (WAO) document endorsed by Allergic Rhinitis and its Impact on Asthma (ARIA) and Global Allergy and Asthma European Network (GA. Asthma Res Pract. 2016;2:12doi: 10.1186/s40733-016-0027-5.
Braido, F., Scichilone, N., Lavorini, F., Usmani, O. S., Dubuske, L., Boulet, L. P., Mosges, R., Nunes, C., Sánchez-Borges, M., Ansotegui, I. J., Ebisawa, M., Levi-Schaffer, F., Rosenwasser, L. J., Bousquet, J., Zuberbier, T., Canonica, G. W. (2016). Manifesto on small airway involvement and management in asthma and chronic obstructive pulmonary disease: an Interasma (Global Asthma Association - GAA) and World Allergy Organization (WAO) document endorsed by Allergic Rhinitis and its Impact on Asthma (ARIA) and Global Allergy and Asthma European Network (GA. Asthma research and practice, 212. https://doi.org/10.1186/s40733-016-0027-5
Braido, F, et al. "Manifesto on small airway involvement and management in asthma and chronic obstructive pulmonary disease: an Interasma (Global Asthma Association - GAA) and World Allergy Organization (WAO) document endorsed by Allergic Rhinitis and its Impact on Asthma (ARIA) and Global Allergy and Asthma European Network (GA." Asthma research and practice vol. 2 (2016): 12. doi: https://doi.org/10.1186/s40733-016-0027-5
Braido F, Scichilone N, Lavorini F, Usmani OS, Dubuske L, Boulet LP, Mosges R, Nunes C, Sánchez-Borges M, Ansotegui IJ, Ebisawa M, Levi-Schaffer F, Rosenwasser LJ, Bousquet J, Zuberbier T, Canonica GW. Manifesto on small airway involvement and management in asthma and chronic obstructive pulmonary disease: an Interasma (Global Asthma Association - GAA) and World Allergy Organization (WAO) document endorsed by Allergic Rhinitis and its Impact on Asthma (ARIA) and Global Allergy and Asthma European Network (GA. Asthma Res Pract. 2016 Oct 28;2:12. doi: 10.1186/s40733-016-0027-5. eCollection 2016. PMID: 27965780; PMCID: PMC5142416.
Copy Download .nbib Format: NLM
Impact of COVID-19 on routine malaria indicators in Uganda: An interrupted time series analysis.

Research square

Namuganga JF, Briggs J, Roh ME, Okiring J, Kisambira Y, Sserwanga A, Kapisi JA, Arinaitwe E, Ebong C, Ssewanyana I, Greenhouse B, Maiteki-Ssebuguzi C, Kamya MR, Staedke SG, Dorsey G, Nankabirwa JI.
PMID: 34426808
Res Sq. 2021 Aug 18; doi: 10.21203/rs.3.rs-819495/v1.

Background In March 2020, the government of Uganda implemented a strict lockdown policy in response to the COVID-19 pandemic. We performed an interrupted time series analysis (ITSA) to assess whether major changes in healthcare seeking behavior, malaria burden, and...

Cite
Namuganga JF, Briggs J, Roh ME, et al. Impact of COVID-19 on routine malaria indicators in Uganda: An interrupted time series analysis. Res Sq. 2021;doi: 10.21203/rs.3.rs-819495/v1.
Namuganga, J. F., Briggs, J., Roh, M. E., Okiring, J., Kisambira, Y., Sserwanga, A., Kapisi, J. A., Arinaitwe, E., Ebong, C., Ssewanyana, I., Greenhouse, B., Maiteki-Ssebuguzi, C., Kamya, M. R., Staedke, S. G., Dorsey, G., & Nankabirwa, J. I. (2021). Impact of COVID-19 on routine malaria indicators in Uganda: An interrupted time series analysis. Research square, . https://doi.org/10.21203/rs.3.rs-819495/v1
Namuganga, Jane Frances, et al. "Impact of COVID-19 on routine malaria indicators in Uganda: An interrupted time series analysis." Research square vol. (2021). doi: https://doi.org/10.21203/rs.3.rs-819495/v1
Namuganga JF, Briggs J, Roh ME, Okiring J, Kisambira Y, Sserwanga A, Kapisi JA, Arinaitwe E, Ebong C, Ssewanyana I, Greenhouse B, Maiteki-Ssebuguzi C, Kamya MR, Staedke SG, Dorsey G, Nankabirwa JI. Impact of COVID-19 on routine malaria indicators in Uganda: An interrupted time series analysis. Res Sq. 2021 Aug 18; doi: 10.21203/rs.3.rs-819495/v1. PMID: 34426808; PMCID: PMC8382131.
Copy Download .nbib Format: NLM
Validity, reliability, and responsiveness of daily monitoring visual analog scales in MASK-air®.

Clinical and translational allergy

Sousa-Pinto B, Eklund P, Pfaar O, Klimek L, Zuberbier T, Czarlewski W, Bédard A, Bindslev-Jensen C, Bedbrook A, Bosnic-Anticevich S, Brussino L, Cardona V, Cruz AA, de Vries G, Devillier P, Fokkens WJ, Fuentes-Pérez JM, Gemicioğlu B, Haahtela T, Huerta-Villalobos YR, Ivancevich JC, Kull I, Kuna P, Kvedariene V, Larenas Linnemann DE, Laune D, Makris M, Melén E, Morais-Almeida M, Mösges R, Mullol J, O'Hehir RE, Papadopoulos NG, Pereira AM, Prokopakis EP, Psarros F, Regateiro FS, Reitsma S, Samolinski B, Scichilone N, da Silva J, Stellato C, Todo-Bom A, Tomazic PV, Salmi ST, Valero A, Valiulis A, Valovirta E, van Eerd M, Ventura MT, Yorgancioglu A, Basagaña X, Antó JM, Bousquet J, Fonseca JA.
PMID: 34567526
Clin Transl Allergy. 2021 Sep 19;11(7):e12062. doi: 10.1002/clt2.12062. eCollection 2021 Aug.

BACKGROUND: MASK-air® is an app that supports allergic rhinitis patients in disease control. Users register daily allergy symptoms and their impact on activities using visual analog scales (VASs). We aimed to assess the concurrent validity, reliability, and responsiveness of...

Cite
Sousa-Pinto B, Eklund P, Pfaar O, et al. Validity, reliability, and responsiveness of daily monitoring visual analog scales in MASK-air®. Clin Transl Allergy. 2021;11(7):e12062doi: 10.1002/clt2.12062.
Sousa-Pinto, B., Eklund, P., Pfaar, O., Klimek, L., Zuberbier, T., Czarlewski, W., Bédard, A., Bindslev-Jensen, C., Bedbrook, A., Bosnic-Anticevich, S., Brussino, L., Cardona, V., Cruz, A. A., de Vries, G., Devillier, P., Fokkens, W. J., Fuentes-Pérez, J. M., Gemicioğlu, B., Haahtela, T., Huerta-Villalobos, Y. R., Ivancevich, J. C., Kull, I., Kuna, P., Kvedariene, V., Larenas Linnemann, D. E., Laune, D., Makris, M., Melén, E., Morais-Almeida, M., Mösges, R., Mullol, J., O'Hehir, R. E., Papadopoulos, N. G., Pereira, A. M., Prokopakis, E. P., Psarros, F., Regateiro, F. S., Reitsma, S., Samolinski, B., Scichilone, N., da Silva, J., Stellato, C., Todo-Bom, A., Tomazic, P. V., Salmi, S. T., Valero, A., Valiulis, A., Valovirta, E., van Eerd, M., Ventura, M. T., Yorgancioglu, A., Basagaña, X., Antó, J. M., Bousquet, J., & Fonseca, J. A. (2021). Validity, reliability, and responsiveness of daily monitoring visual analog scales in MASK-air®. Clinical and translational allergy, 11(7), e12062. https://doi.org/10.1002/clt2.12062
Sousa-Pinto, Bernardo, et al. "Validity, reliability, and responsiveness of daily monitoring visual analog scales in MASK-air®." Clinical and translational allergy vol. 11,7 (2021): e12062. doi: https://doi.org/10.1002/clt2.12062
Sousa-Pinto B, Eklund P, Pfaar O, Klimek L, Zuberbier T, Czarlewski W, Bédard A, Bindslev-Jensen C, Bedbrook A, Bosnic-Anticevich S, Brussino L, Cardona V, Cruz AA, de Vries G, Devillier P, Fokkens WJ, Fuentes-Pérez JM, Gemicioğlu B, Haahtela T, Huerta-Villalobos YR, Ivancevich JC, Kull I, Kuna P, Kvedariene V, Larenas Linnemann DE, Laune D, Makris M, Melén E, Morais-Almeida M, Mösges R, Mullol J, O'Hehir RE, Papadopoulos NG, Pereira AM, Prokopakis EP, Psarros F, Regateiro FS, Reitsma S, Samolinski B, Scichilone N, da Silva J, Stellato C, Todo-Bom A, Tomazic PV, Salmi ST, Valero A, Valiulis A, Valovirta E, van Eerd M, Ventura MT, Yorgancioglu A, Basagaña X, Antó JM, Bousquet J, Fonseca JA. Validity, reliability, and responsiveness of daily monitoring visual analog scales in MASK-air®. Clin Transl Allergy. 2021 Sep 19;11(7):e12062. doi: 10.1002/clt2.12062. eCollection 2021 Aug. PMID: 34567526; PMCID: PMC8449952.
Copy Download .nbib Format: NLM
Closing the gap: A novel metric of change in performance.

East African journal of applied health monitoring and evaluation

Katuramu R, Wallenta J, Semitala FC, Amanyire G, Kampiire L, Namusobya J, Kamya MR, Havlir D, Glidden DV, Geng E.
PMID: 32817932
East Afr J Appl Health Monitor Eval. 2019 Feb;2019(3).

BACKGROUND: Interventions to improve performance of global programs in the HIV cascade of care are widespread and increasing the focus of implementation science. At present, however, there is no clear consensus on how to conceptualize their improvement at the...

Cite
Katuramu R, Wallenta J, Semitala FC, et al. Closing the gap: A novel metric of change in performance. East Afr J Appl Health Monitor Eval. 2019;2019(3)
Katuramu, R., Wallenta, J., Semitala, F. C., Amanyire, G., Kampiire, L., Namusobya, J., Kamya, M. R., Havlir, D., Glidden, D. V., & Geng, E. (2019). Closing the gap: A novel metric of change in performance. East African journal of applied health monitoring and evaluation, 2019(3), .
Katuramu, Richard, et al. "Closing the gap: A novel metric of change in performance." East African journal of applied health monitoring and evaluation vol. 2019,3 (2019).
Katuramu R, Wallenta J, Semitala FC, Amanyire G, Kampiire L, Namusobya J, Kamya MR, Havlir D, Glidden DV, Geng E. Closing the gap: A novel metric of change in performance. East Afr J Appl Health Monitor Eval. 2019 Feb;2019(3). PMID: 32817932; PMCID: PMC7428843.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 134 entries